SEC Form 4 · accession 0001209191-17-047540
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Duggan
10% Owner
Period of report
Aug 1, 2017
Accepted (ET)
Aug 3, 2017 · 7:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2017 | P | 42,990 | $20.20 | A | 3,153,234 | D | |
| Common StockF2 | Aug 1, 2017 | P | 17,010 | $20.945 | A | 3,170,244 | D | |
| Common StockF3 | Aug 1, 2017 | P | 8,000 | $22.748 | A | 3,178,244 | D | |
| Common StockF4 | Aug 1, 2017 | P | 80,618 | $23.476 | A | 3,258,862 | D | |
| Common StockF5 | Aug 1, 2017 | P | 6,868 | $24.018 | A | 3,265,730 | D | |
| Common StockF6 | Aug 2, 2017 | P | 14,710 | $24.372 | A | 3,280,440 | D | |
| Common StockF7 | Aug 2, 2017 | P | 38,290 | $25.121 | A | 3,318,730 | D | |
| Common StockF8 | Aug 3, 2017 | P | 68,964 | $23.704 | A | 3,387,694 | D | |
| Common StockF9 | holding | — | — | — | 35,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is the weighted average purchase price of the shares, which ranged from $19.64 to $20.626 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F2This is the weighted average purchase price of the shares, which ranged from $20.646 to $21.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F3This is the weighted average purchase price of the shares, which ranged from $21.94 to $22.939 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F4This is the weighted average purchase price of the shares, which ranged from $22.998 to $23.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F5This is the weighted average purchase price of the shares, which ranged from $24.00 to $24.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F6This is the weighted average purchase price of the shares, which ranged from $23.885 to $24.88 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F7This is the weighted average purchase price of the shares, which ranged from $24.89 to $25.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F8This is the weighted average purchase price of the shares, which ranged from $23.121 to $23.916 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- F9Shares are held by Genius Incorporated, of which the Reporting Person is the sole member and beneficiary.